Biologic Therapeutic Drugs: Technologies and Global
Markets refers to a report that looks at treatments made from
living substances and examines how they're developed and sold
worldwide.
BOSTON, April 18,
2024 /PRNewswire/ -- "According to the latest
research study, the demand for Biologic Therapeutic Drugs:
Technologies and Global Markets expected to grow from
$452.9 in 2023 to reach $823.4 billion by the end of 2028 at a compound
annual growth rate (CAGR) of 12.7% during the forecast period of
2023-2028."
This report examines the biologics market, describing its
current state and future possibilities. It looks at important
factors such as competition, regulations, what's driving the
market, and trends, predicting trends until 2028. The market is
analyzed by types of products, what they're used for, and where
they come from, like therapeutic proteins and cancer treatments
sourced from humans, animals, or micro-organisms. It also looks at
where these things are happening, such as in North America, Europe, and Asia-Pacific. The estimates are based on 2022
data, with forecasts up to 2028, providing useful insights for
stakeholders.
Biologics are produced from various sources, including fermented
cells and transgenic plant cells. Cell and gene therapy are vital
in modern biologic manufacturing. The
United States leads globally in utilizing biologics to treat
a wide range of diseases, whether they're rare or chronic.
Discover the World of Biologic Therapy: Tap into Market
Opportunities! Click here for insightful research and strategic
insights.
Main Factors Powering Biologic Therapeutic Drugs:
Technologies and Global Markets:
- Rising Prevalence of Chronic Diseases: More and more
people are getting stuck with long-term health problems like heart
disease, diabetes, and some cancers, and it's happening a lot
everywhere.
- Advancement in Biologics: means getting better at making
and using medicines from living things. This includes finding new
ways to make them, understanding how they work in our bodies, and
discovering new treatments for different diseases.
- Development in Cell and Gene Therapy Methodology: means
getting better at treating diseases by fixing or changing genes or
cells inside the body. This includes finding new ways to give gene
therapy, change genes, and control cells to fight specific
diseases. These improvements offer hope for treating many different
conditions, like genetic disorders and some types of cancer.
- Increase in Infectious and Chronic Diseases: means that
more people are getting sick with contagious diseases like the flu
or COVID-19, as well as long-term health issues like diabetes or
heart disease. This uptick in illnesses could be because of things
like changes in how we live, the environment, or not having enough
access to healthcare.
Request a Sample Copy of the Biologic Therapeutic
Drugs: Technologies and Global Markets
Report
Synopsis
Report
Metrics
|
Details
|
Base year
considered
|
2022
|
Forecast Period
considered
|
2023-2028
|
Base year market
size
|
$419.0
billion
|
Market Size
Forecast
|
$823.4
billion
|
Growth Rate
|
CAGR of 12.7% for the
forecast period of 2023-2028
|
Segment
Covered
|
Product, Application,
Source
|
Regions
covered
|
North America, Europe,
Asia-Pacific, Rest of the World (RoW)
|
Countries
covered
|
U.S., Canada, Mexico,
Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Norway,
Poland, Belgium, Austria, the Netherlands, Sweden, Russia, Japan,
China, India, Australia, New Zealand, Taiwan, Singapore, Malaysia,
Thailand, Philippines, South Korea, Indonesia, GCC countries,
Colombia, Peru
|
Key Market
Drivers
|
- Rising Prevalence
of Chronic Diseases
- Advancement in
Biologics
- Development in Cell
and Gene Therapy Methodology
- Increase in
Infectious and Chronic Diseases
|
Report Segmentation: Understanding Biologic Drugs: How
They're Divided in Global Markets:
- Product: When it comes to products, they're talking
about different kinds of treatments. These include therapeutic
proteins, vaccines, cell and gene therapy, and some other
options.
- Application: In terms of application, these treatments
are used for various purposes. This includes treating cancer,
autoimmune conditions, aesthetic procedures, eye disorders, and
some other uses.
- Source: In terms of where these treatments come from,
they can be sourced from humans, animals, micro-organisms,
fermented cells, or sometimes from other sources.
This report gives a detailed look at biologic drugs,
including how they're made and sold worldwide. It provides thorough
analysis and answers important questions:
- What is the projected market size and growth rate of the
market?
The market is projected to grow from $419.0
billion in 2022 to $823.4
billion in 2028, at a compound annual growth rate (CAGR) of
12.7% during the forecast period.
- What are the key factors driving the growth of the market?
The key factors driving the growth of the Global Market of Research
Antibodies
Rising Prevalence of Chronic Diseases
Advancement in Biologics
Development in Cell and Gene Therapy Methodology
Increase in Infectious and Chronic Diseases.
- What segments are covered in the market?
The Global Market of Research Antibodies is segmented based on
Application
Source
Product
- By product, which segment will dominate the market by the end
of 2028?
By product, Therapeutic Proteins segment is anticipated to dominate
the market by the end of 2028.
- Which region has the highest market share in the market?
North America holds the highest
market share in the market in terms of region.
Some of the Key Market Players Are:
- ABBVIE INC.
- AMGEN INC.
- BAXTER
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- CSL LTD.
- DENDREON PHARMACEUTICALS LLC.
- Eli Lilly and Co.
- F. HOFFMANN-LA ROCHE LTD.
- GLAXOSMITHKLINE PLC
- GLYCOTOPE GMBH
- GRIFOLS S.A.
- JSC PHARMSTANDARD
- KEDRION S.P.A.
- LONZA
- MERCK & CO. INC.
- NOVARTIS AG
- OCTAPHARMA AG
- RELIANCE LIFE SCIENCES
- SANOFI
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
Browse for more related reports:
Global Markets for Research Antibodies: is about the worldwide
sale of antibodies used by scientists to study proteins and other
molecules in living things. These antibodies help researchers in
fields like biology, medicine, and biotechnology understand how
things work in our bodies.
Directly Purchase a copy of the report with BCC
Research.
For further information or to make a purchase, please get in
touch with info@bccresearch.com.
About BCC Research
BCC Research provides objective, unbiased measurement and
assessment of market opportunities with detailed market research
reports. Our experienced industry analysts' goal is to help you
make informed business decisions, free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our
media page for access to our market research library.
Data and analysis extracted from this press release must be
accompanied by a statement identifying BCC Research LLC as the
source and publisher.
Logo:
https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/big-growth-ahead-biologic-drugs-market-to-hit-823-4-billion-by-2028--reveals-bcc-research-302120824.html
SOURCE BCC Research LLC